Grow your business safely with ADK Pharma
All the information you need about ADK Pharma to develop and secure your business in France
A
HOME >
CORPORATES
>
ADK Pharma >
BALANCE SHEET (
2023-02-03)
THE LIST OF BALANCE SHEET : ADK Pharma
| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2023-02-03 | Public | 2022-06-30 | Complete |
| Name | ADK Pharma |
| Siren | 891969180 |
| Closing | 2022-06-30 |
| Registry code | 5952 |
| Registration number | 402 |
| Management number | 2020D00478 |
| Activity code | 6430Z |
| Closing date n-1 | 2021-06-30 |
| Duration Fiscal year | 12 |
| Duration Fiscal year n-1 | 03 |
| Filing date | 2023-02-03 |
| Modification | 00 Annual accounts entered without anomaly |
| Balance sheet type | C : Complete |
| Currency code | EUR |
| Confidentiality | Public |
| Address | 59286 Roost-Warendin |
| 1 - Assets (balance sheet) | Gross amount year N | Amortization year N | Net year N | Net year N-1 |
BJ TOTAL (I) | 99 998.00 | 99 998.00 | 99 998.00 | |
BZ Other receivables | 200 001.00 | 200 001.00 | 200 001.00 | |
CF Cash and cash equivalents | 1 412.00 | 1 412.00 | 1 412.00 | |
CJ TOTAL (II) | 201 413.00 | 201 413.00 | 201 413.00 | |
CO Grand total (0 to V) | 301 411.00 | 301 411.00 | 301 411.00 | |
CU Other investments | 99 998.00 | 99 998.00 | 99 998.00 | |
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | ||
DA Share or individual capital | 10 000.00 | 10 000.00 | 10 000.00 | |
DH Retained earnings | -2 466.00 | -2 466.00 | ||
DI RESULTS FOR THE YEAR (Profit or Loss) | -1 365.00 | -2 466.00 | -1 365.00 | |
DL TOTAL (I) | 6 168.00 | 7 533.00 | 6 168.00 | |
DV Miscellaneous Loans and Financial Debts (4) | 293 000.00 | 147 999.00 | 293 000.00 | |
DX Trade payables and related accounts | 2 243.00 | 2 466.00 | 2 243.00 | |
EC TOTAL (IV) | 295 243.00 | 150 466.00 | 295 243.00 | |
EE Grand total (I to V) | 301 411.00 | 157 999.00 | 301 411.00 | |
EG Accrued income and payables due within one year | 295 243.00 | 150 466.00 | 295 243.00 | |
| 3 - Income statement | Amount France year N | Amount Export year N | Total year N | Total year N-1 |
FW Other purchases and external expenses | 1 365.00 | |||
GF Total Operating Expenses (II) | 1 365.00 | |||
GG - OPERATING RESULT (I - II) | -1 365.00 | |||
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) | -1 365.00 | |||
| 4 - Income statement (continued) | Amount year N | Amount year N-1 | ||
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) | 1 365.00 | 2 466.00 | 1 365.00 | |
HN PROFIT OR LOSS (Total revenue - Total expenses) | -1 365.00 | -2 466.00 | -1 365.00 | |
| 5 - Fixed assets increase - decrease | Gross value at beginning of year - Item by item | Revaluation - Disposals | Acquisition - Gross value at year-end | |
0G ACQUISITIONS Total General Total | 67 998.00 | 31 999.00 | 67 998.00 | |
I3 DECREASES Total Financial Fixed Assets | 99 998.00 | |||
I4 DECREASES Grand Total | 99 998.00 | |||
LQ ACQUISITIONS Total Financial Fixed Assets | 67 998.00 | 31 999.00 | 67 998.00 | |
| 8 - Receivables and payables | Gross amount | Amount within 1 year | Amount 1 to 5 years | Amount more than 5 years |
8B Suppliers and Related Accounts | 2 243.00 | 2 243.00 | 2 243.00 | |
VI Group and Associates | 293 000.00 | 293 000.00 | 293 000.00 | |
VR Miscellaneous debtors (including receivables related to repo transactions) | 200 001.00 | 200 001.00 | 200 001.00 | |
VT TOTAL – STATEMENT OF RECEIVABLES | 200 001.00 | 200 001.00 | 200 001.00 | |
VY TOTAL – STATEMENT OF LIABILITIES | 295 243.00 | 295 243.00 | 295 243.00 | |
all companies in France
Complete and comprehensive database.
